Clinical Trial

Genflow Completes Dosing Phase of Canine Gene Therapy Trial

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET…

2 months ago

President Trump Cleaning Up Biden’s Marijuana Mess – MMJ Preparing to Move FDA Huntington’s Cannabis Trials Forward

Trump Prepares to Clean Up Biden's "Do-Nothing" Marijuana Mess: Why MMJ International Holdings Takes the Lead in a Pharmaceutical Cannabis…

2 months ago

Lunit Announces Collaboration with Daiichi Sankyo to Advance AI-Driven Biomarker Discovery and Translational Oncology Research

Collaboration to leverage Lunit SCOPE IO ® and SCOPE universal IHC® (uIHC) digital pathology products in two Daiichi Sankyo oncology…

2 months ago

Rigani Press Announces Breakthrough Book for Health IT and Medical Leaders to Forge the Road to Responsible AI

Rushing Headlong: Health IT's Legacy and the Road to Responsible AI by Dr. S. Yin Ho is an indispensable book…

2 months ago

Apyron Pioneering Next Generation Pain Management Solutions

Atlanta, Georgia--(Newsfile Corp. - December 15, 2025) - Apyron, Inc. is a medical technology company with a product portfolio designed…

2 months ago

Aytu BioPharma Announces Commercial Availability of EXXUA(TM) (gepirone) Extended-Release Tablets, the First and Only 5HT1a Agonist Indicated for the Treatment of Major Depressive Disorder in Adults

EXXUA is now available through Aytu RxConnect® pharmacies to ensure optimal access and availabilityEXXUA has demonstrated significant improvement in depression…

2 months ago

Jaguar Health Announces Abstract Submission for Preliminary Data from US Investigator-Initiated Trial of Crofelemer in Adult Patients with Short Bowel Syndrome with Intestinal Failure (SBS-IF)

SBS-IF is the second orphan disease target indication for Jaguar's intestinal failure program, which includes microvillus inclusion disease (MVID) -…

2 months ago

EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna’s mNEXSPIKE (COVID-19 Vaccine, mRNA)

mNEXSPIKE is Moderna's third product to receive a positive CHMP opinion alongside Spikevax (COVID-19 Vaccine, mRNA) and mRESVIA (Respiratory Syncytial…

2 months ago

Piramal Pharma Solutions Demonstrates Commitment to Excellence with Outstanding Net Promoter Score

Piramal Pharma Solutions recently achieved a net promoter score (NPS) of 55, far surpassing industry averages. A third-party provider, DNV,…

2 months ago